Ki-67 expression as an indicator of invasiveness in patients with breast cancer

Background: Tumor markers have a key role in guiding breast cancer management protocols and predicting prognosis. Objective: The aim of the study is to explore the role of Ki-67 expression in breast cancer and correlate it to well-known indicators of invasiveness such as age, tumor size, grade, horm...

Full description

Bibliographic Details
Main Authors: Ahmed Salah Mahdi, Hayder Hussein Ibrahim, Ayad Ahmad Mohammed
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Medical Journal of Babylon
Subjects:
Online Access:http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2018;volume=15;issue=4;spage=271;epage=275;aulast=Mahdi
_version_ 1818941927669628928
author Ahmed Salah Mahdi
Hayder Hussein Ibrahim
Ayad Ahmad Mohammed
author_facet Ahmed Salah Mahdi
Hayder Hussein Ibrahim
Ayad Ahmad Mohammed
author_sort Ahmed Salah Mahdi
collection DOAJ
description Background: Tumor markers have a key role in guiding breast cancer management protocols and predicting prognosis. Objective: The aim of the study is to explore the role of Ki-67 expression in breast cancer and correlate it to well-known indicators of invasiveness such as age, tumor size, grade, hormonal receptors, and lymph nodes involvement. Materials and Methods: This retrospective study was conducted on (214) patients who were newly diagnosed with breast cancer and referred to Azadi Teaching Hospital/Duhok-Iraq, from November 1st, 2016, to October 31st, 2017. Data regarding patient's demographics, tumor size, histological type and grade, nuclear grade, and lymph node involvement were obtained from medical records. Patients underwent either mastectomy with axillary lymph node dissection or breast conservation surgery. Collected specimens were sent for histopathological examination and immunohistochemistry assessments of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor 2 (HER2), and Ki67 expressions. Results: Our study showed that histological grade, nuclear grade, mitotic index, and HER2 status were positively correlated to Ki67 index (P < 0.05). Furthermore, ER and PR status showed a negative correlation to Ki67 index (P < 0.05). Age, tumor size, and the number of lymph nodes involved displayed no significant correlation to Ki67 level (P = 0.080, 0.738, and 0.888), respectively. Conclusion: Results of this study confirmed that Ki67 index are significantly correlated with tumor grade, ER, PR, and HER2 status. However, Ki67 expression association with other clinic-pathological parameters such as age, tumor size, or lymph node involvement is not recognized and requires further studies.
first_indexed 2024-12-20T07:03:19Z
format Article
id doaj.art-f1abf8ed154a483d807687baec46cc44
institution Directory Open Access Journal
issn 1812-156X
2312-6760
language English
last_indexed 2024-12-20T07:03:19Z
publishDate 2018-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Medical Journal of Babylon
spelling doaj.art-f1abf8ed154a483d807687baec46cc442022-12-21T19:49:09ZengWolters Kluwer Medknow PublicationsMedical Journal of Babylon1812-156X2312-67602018-01-0115427127510.4103/MJBL.MJBL_54_18Ki-67 expression as an indicator of invasiveness in patients with breast cancerAhmed Salah MahdiHayder Hussein IbrahimAyad Ahmad MohammedBackground: Tumor markers have a key role in guiding breast cancer management protocols and predicting prognosis. Objective: The aim of the study is to explore the role of Ki-67 expression in breast cancer and correlate it to well-known indicators of invasiveness such as age, tumor size, grade, hormonal receptors, and lymph nodes involvement. Materials and Methods: This retrospective study was conducted on (214) patients who were newly diagnosed with breast cancer and referred to Azadi Teaching Hospital/Duhok-Iraq, from November 1st, 2016, to October 31st, 2017. Data regarding patient's demographics, tumor size, histological type and grade, nuclear grade, and lymph node involvement were obtained from medical records. Patients underwent either mastectomy with axillary lymph node dissection or breast conservation surgery. Collected specimens were sent for histopathological examination and immunohistochemistry assessments of estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor 2 (HER2), and Ki67 expressions. Results: Our study showed that histological grade, nuclear grade, mitotic index, and HER2 status were positively correlated to Ki67 index (P < 0.05). Furthermore, ER and PR status showed a negative correlation to Ki67 index (P < 0.05). Age, tumor size, and the number of lymph nodes involved displayed no significant correlation to Ki67 level (P = 0.080, 0.738, and 0.888), respectively. Conclusion: Results of this study confirmed that Ki67 index are significantly correlated with tumor grade, ER, PR, and HER2 status. However, Ki67 expression association with other clinic-pathological parameters such as age, tumor size, or lymph node involvement is not recognized and requires further studies.http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2018;volume=15;issue=4;spage=271;epage=275;aulast=MahdiBiomarkersbreast cancerimmunohistochemistryKi-67 antigen
spellingShingle Ahmed Salah Mahdi
Hayder Hussein Ibrahim
Ayad Ahmad Mohammed
Ki-67 expression as an indicator of invasiveness in patients with breast cancer
Medical Journal of Babylon
Biomarkers
breast cancer
immunohistochemistry
Ki-67 antigen
title Ki-67 expression as an indicator of invasiveness in patients with breast cancer
title_full Ki-67 expression as an indicator of invasiveness in patients with breast cancer
title_fullStr Ki-67 expression as an indicator of invasiveness in patients with breast cancer
title_full_unstemmed Ki-67 expression as an indicator of invasiveness in patients with breast cancer
title_short Ki-67 expression as an indicator of invasiveness in patients with breast cancer
title_sort ki 67 expression as an indicator of invasiveness in patients with breast cancer
topic Biomarkers
breast cancer
immunohistochemistry
Ki-67 antigen
url http://www.medjbabylon.org/article.asp?issn=1812-156X;year=2018;volume=15;issue=4;spage=271;epage=275;aulast=Mahdi
work_keys_str_mv AT ahmedsalahmahdi ki67expressionasanindicatorofinvasivenessinpatientswithbreastcancer
AT hayderhusseinibrahim ki67expressionasanindicatorofinvasivenessinpatientswithbreastcancer
AT ayadahmadmohammed ki67expressionasanindicatorofinvasivenessinpatientswithbreastcancer